Drug intelligence / Profile preview

KizaVie

Development stage
Unknown
Lead developer
LEAF4Life
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

KizaVie (Liposomal Transcrocetin or L-TC) is a novel liposomal formulation of trans sodium crocetinate (TSC) developed by LEAF4Life. It is designed to enhance oxygen diffusion in the plasma and interstitium, specifically targeting tumor hypoxia, which is a common cause of resistance to radiation and chemotherapy. By normalizing tumor vasculature and providing a transient increase in tumor oxygenation, KizaVie acts as a radiosensitizer, making hypoxic tumor cells more susceptible to radiation therapy. It is currently being evaluated in the Phase III THREE-GLEES trial, sponsored by the Institut de cancérologie Strasbourg Europe, for the treatment of newly diagnosed glioblastoma in combination with hypofractionated radiotherapy and temozolomide.

Brand names
KizaVie
Other names
Liposomal TranscrocetinLiposomal Trans Sodium Crocetinatetrans sodium crocetinate liposomal
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on KizaVie.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KizaVie.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call